Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 123

1.

Recurrent glomerulonephritis after kidney transplantation: risk factors and allograft outcomes.

Allen PJ, Chadban SJ, Craig JC, Lim WH, Allen RDM, Clayton PA, Teixeira-Pinto A, Wong G.

Kidney Int. 2017 Aug;92(2):461-469. doi: 10.1016/j.kint.2017.03.015.

PMID:
28601198
2.

Expectations and experiences of follow up and self-care after living kidney donation: a focus group study.

Manera KE, Hanson CS, Chapman JR, Kanellis J, Gill J, Craig JC, Chadban SJ, Wong G, Ralph AF, Tong A.

Transplantation. 2017 May 24. doi: 10.1097/TP.0000000000001771. [Epub ahead of print]

PMID:
28538499
3.

Organ Transplantation in Australia.

Alexander SI, Clayton PA, Chadban SJ.

Transplantation. 2017 May;101(5):891-892. doi: 10.1097/TP.0000000000001621. No abstract available.

PMID:
28437382
4.

Clinical Trials for Immunosuppression in Transplantation: The Case for Reform and Change in Direction.

OʼConnell PJ, Kuypers DR, Mannon RB, Abecassis M, Chadban SJ, Gill JS, Murphy B, Nickerson PW, Schold JD, Stock PG, Seron D, Alloway RR, Bromberg JS, Budde K, Jordan SC, Legendre C, Lefaucheur C, Sarwall M, Segev DL, Stegall MD, Tullius SG, Wong G, Woodle ES, Ascher N, Morris RE.

Transplantation. 2017 Jul;101(7):1527-1534. doi: 10.1097/TP.0000000000001648.

PMID:
28207630
5.

The risk of cancer in kidney transplant recipients may be reduced in those maintained on everolimus and reduced cyclosporine.

Lim WH, Russ GR, Wong G, Pilmore H, Kanellis J, Chadban SJ.

Kidney Int. 2017 Apr;91(4):954-963. doi: 10.1016/j.kint.2016.11.008. Epub 2017 Jan 18.

PMID:
28109543
6.

Long-term outcomes of kidney transplantation in people with type 2 diabetes: a population cohort study.

Lim WH, Wong G, Pilmore HL, McDonald SP, Chadban SJ.

Lancet Diabetes Endocrinol. 2017 Jan;5(1):26-33. doi: 10.1016/S2213-8587(16)30317-5.

PMID:
28010785
7.

Donor and Recipient Views on Their Relationship in Living Kidney Donation: Thematic Synthesis of Qualitative Studies.

Ralph AF, Butow P, Hanson CS, Chadban SJ, Chapman JR, Craig JC, Kanellis J, Luxton G, Tong A.

Am J Kidney Dis. 2017 May;69(5):602-616. doi: 10.1053/j.ajkd.2016.09.017. Epub 2016 Nov 23. Review.

PMID:
27889296
8.

Relationship between eGFR Decline and Hard Outcomes after Kidney Transplants.

Clayton PA, Lim WH, Wong G, Chadban SJ.

J Am Soc Nephrol. 2016 Nov;27(11):3440-3446. Epub 2016 Apr 8.

PMID:
27059513
9.

Josette Marie Eris April 7, 1959 to April 6, 2016 TTS Councilor and Professor.

Chadban SJ.

Transplantation. 2016 Aug;100(8):1596. doi: 10.1097/TP.0000000000001337. No abstract available.

PMID:
27454917
10.

Patient awareness and beliefs about the risk factors and comorbidities associated with chronic kidney disease : A mixed-methods study.

Lopez-Vargas PA, Tong A, Howell M, Phoon RK, Chadban SJ, Shen Y, Craig JC.

Nephrology (Carlton). 2017 May;22(5):374-381. doi: 10.1111/nep.12829.

PMID:
27248507
11.

Improving Our Understanding of Quality of Life in CKD.

Wyld ML, Chadban SJ, Morton RL.

Am J Kidney Dis. 2016 Jun;67(6):820-1. doi: 10.1053/j.ajkd.2016.03.412. No abstract available.

PMID:
27211365
12.

Risk-Factor Profile of Living Kidney Donors: The Australia and New Zealand Dialysis and Transplant Living Kidney Donor Registry 2004-2012.

Clayton PA, Saunders JR, McDonald SP, Allen RD, Pilmore H, Saunder A, Boudville N, Chadban SJ.

Transplantation. 2016 Jun;100(6):1278-83. doi: 10.1097/TP.0000000000000877.

PMID:
27123877
13.
14.

Recurrent IgA Nephropathy After Kidney Transplantation.

Wyld ML, Chadban SJ.

Transplantation. 2016 Sep;100(9):1827-32. doi: 10.1097/TP.0000000000001093. Review.

PMID:
26895219
15.

Attitudes and beliefs about deceased organ donation in the Arabic-speaking community in Australia: a focus group study.

Ralph AF, Alyami A, Allen RD, Howard K, Craig JC, Chadban SJ, Irving M, Tong A.

BMJ Open. 2016 Jan 19;6(1):e010138. doi: 10.1136/bmjopen-2015-010138.

16.

Cancer in ESRD: Clear on the Epidemiology, Hazy on the Mechanisms.

Lim WH, Chadban SJ.

J Am Soc Nephrol. 2016 May;27(5):1272-5. doi: 10.1681/ASN.2015091021. Epub 2015 Nov 12. No abstract available.

17.

Waiting Time Between Failure of First Graft and Second Kidney Transplant and Graft and Patient Survival.

Wong G, Chua S, Chadban SJ, Clayton P, Pilmore H, Hughes PD, Ferrari P, Lim WH.

Transplantation. 2016 Aug;100(8):1767-75. doi: 10.1097/TP.0000000000000953.

PMID:
26457605
18.

Nephrologists' Perspectives on Recipient Eligibility and Access to Living Kidney Donor Transplantation.

Hanson CS, Chadban SJ, Chapman JR, Craig JC, Wong G, Tong A.

Transplantation. 2016 Apr;100(4):943-53. doi: 10.1097/TP.0000000000000921.

PMID:
26425873
19.

Cross-sectional analysis of nutrition and serum uric acid in two Caucasian cohorts: the AusDiab Study and the Tromsø study.

Zykova SN, Storhaug HM, Toft I, Chadban SJ, Jenssen TG, White SL.

Nutr J. 2015 May 14;14:49. doi: 10.1186/s12937-015-0032-1.

20.

Cost to government and society of chronic kidney disease stage 1-5: a national cohort study.

Wyld ML, Lee CM, Zhuo X, White S, Shaw JE, Morton RL, Colagiuri S, Chadban SJ.

Intern Med J. 2015 Jul;45(7):741-7. doi: 10.1111/imj.12797.

PMID:
25944415

Supplemental Content

Loading ...
Support Center